Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2008 Jan;18(1):139-43.
doi: 10.1007/s11695-007-9365-y. Epub 2007 Dec 14.

Intestinal bacterial overgrowth after Roux-en-Y gastric bypass

Affiliations
Case Reports

Intestinal bacterial overgrowth after Roux-en-Y gastric bypass

Juliana Deh Carvalho Machado et al. Obes Surg. 2008 Jan.

Abstract

The aim of the present study was to report the occurrence of serious subnutrition, associated to intestinal bacterial overgrowth, in two patients submitted to bariatric surgery. Two female patients (body mass index, 49 and 50 kg/m(2), respectively) were submitted to Y-en-Roux gastric bypass. The first patient evolved a 52% loss of body weight within 21 months after surgery; the other, a 34% loss of initial body weight within 15 months after surgery, results corresponding, respectively, to 62 and 45 kg weight losses. However, both patients reported asthenia, hair fallout, and edema, and one also reported diarrhea, but none was feverish. Their respective albuminemias were of 24 and 23 g/l. A respiratory hydrogen test suggested bacterial hyperproliferation. Thirty days after ciprofloxacin and tetracyclin treatments, they showed improved albumin levels and nutritional states, both confirmed by results of hydrogen breath tests. Bacterial overgrowth is an important complication that can compromise clinical evolution of patients submitted to intestinal surgery like gastroplasty with Y-Roux anastomosis. In cases of clinical suspicion or a confirmed diagnosis, adequate antibiotics, sometimes requiring to be cyclically repeated, should be administered.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Aliment Pharmacol Ther. 2005 Apr 15;21(8):985-92 - PubMed
    1. Am J Gastroenterol. 2005 Jul;100(7):1566-70 - PubMed
    1. Gut. 2001 Feb;48(2):206-11 - PubMed
    1. N Engl J Med. 2004 Dec 23;351(26):2683-93 - PubMed
    1. Gastroenterology. 1981 Feb;80(2):313-20 - PubMed

Publication types